1-8 of 8
Stefan Kubicek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor

Ruochen Jia, Thomas Balligand, Vasyl Atamanyuk, Harini Nivarthi, Erica Xu, Leon Kutzner, Jakob Weinzierl, Audrey Nedelec, Stefan Kubicek, Roman Lesyk, Oleh Zagrijtschuk, Stefan N. Constantinescu, Robert Kralovics
Journal: Blood
Blood (2021) 137 (14): 1920–1931.
https://doi.org/10.1182/blood.2020006264
Published: 2021
Includes: Supplemental data
Journal Articles

Combination of Venetoclax and Ibrutinib Increases bcl2-Dependent Apoptotic Priming, Reduces ITK-Phosphorylation and Is Clinically Promising in Relapsed/Refractory T-Prolymphocytic Leukemia

Christoph Kornauth, Charles Herbaux, MD MSc, Bernd Boidol, PhD, Chantal Guillemette, Patrick Caron, Stéphanie Poulain, MD PhD, Olivier Tournilhac, Marius E Mayerhoefer, Ulrich Jaeger, MD, Stefan Kubicek, Matthew S. Davids, MD, Philipp Bernhard Staber, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3965.
https://doi.org/10.1182/blood-2019-124392
Published: 2019
Journal Articles

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia

Philipp B. Staber, Marco Herling, Mar Bellido, Eric D. Jacobsen, Matthew S. Davids, Tapan Mahendra Kadia, Andrei Shustov, Olivier Tournilhac, Emmanuel Bachy, Francesco Zaja, Kimmo Porkka, Gregor Hoermann, Ingrid Simonitsch-Klupp, Claudia Haferlach, Stefan Kubicek, Marius E. Mayerhoefer, Georg Hopfinger, Ulrich Jaeger, Claire Dearden
Journal: Blood
Blood (2019) 134 (14): 1132–1143.
https://doi.org/10.1182/blood.2019000402
Published: 2019
Journal Articles

First in Human Response of BCL-2 Inhibitor Venetoclax in T-Cell Prolymphocytic Leukemia

Bernd Boidol, Christoph Kornauth, MD, Emiel van der Kouwe, Nicole Prutsch, Lukas Kazianka, MD, Gregor Hoermann, MD, Georg Hopfinger, MD, Alexander Hauswirth, MD, Marie-Bernadette Aretin, Wolfgang R. Sperr, MD, Peter Valent, MD, Ingrid Simonitsch-Klupp, MD, Richard Morrigl, PhD, Olaf Merkel, PhD, Lukas Kenner, MD, Ulrich Jaeger, MD, Stefan Kubicek, PhD, Philipp Bernhard Staber, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 575.
https://doi.org/10.1182/blood.V130.Suppl_1.575.575
Published: 2017
Journal Articles

Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies

Philipp Bernhard Staber, MD PhD, Berend Snijder, PhD, Gregory Ian Vladimer, PhD, Nikolaus Krall, PhD, Katsuhiro Miura, MD, Ann-Sofie Schmolke, Christoph Kornauth, MD, Oscar Lopez de la Fuente, BSc, Hye-Soo Choi, Emiel van der Kouwe, Lukas Kazianka, MD, Johannes Bigenzahn1, MD PhD, Gregor Hoermann, MD, Nicole Prutsch, Olaf Merkel, PhD, Anna Ringler, Georg Jeryczynski, MD, Marius Mayerhoefer, MD, Ingrid Simonitsch-Klupp, MD, Franz X Felberbauer, MD, Leonhard Muellauer, MD PhD, Gerald W Prager, MD, Belgin Korkmaz, MD, Lukas Kenner, MD, Wolfgang R. Sperr, MD, Robert Kralovics, PhD, Heinz Gisslinger, Peter Valent, MD, Stefan Kubicek, PhD, Ulrich Jaeger, MD, Giulio Superti-Furga, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 855.
https://doi.org/10.1182/blood.V130.Suppl_1.855.855
Published: 2017
Journal Articles

Integrated ATAC-Seq and Chemosensitivity Profiling Identifies Rational Drug Combinations in Ibrutinib-Treated CLL Patients

Gregory Ian Vladimer, PhD, Christian Schmidl, PhD, Andre Renderio, MS, Susanne Schnabl, MS, Tea Pemovska, PhD, Berend Snijder, PhD, Thomas Krausgruber, PhD, Nikolaus Krall, PhD, Mohammad Araghi, Rainer Hubmann, Anna Ringler, Dita Demirtas, Oscar Lopez de la Fuente, BSc, Martin Hilgrath, Cathrin Skrabs, MD, Edit Anna Porpaczy, MD, Michaela Gruber, MD PhD, Gregor Hoermann, MD, Stefan Kubicek, PhD, Philipp Bernhard Staber, MD PhD, Medhat M. Shehata, MD, Giulio Superti-Furga, PhD, Christoph Bock, PhD, Ulrich Jaeger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 800.
https://doi.org/10.1182/blood.V130.Suppl_1.800.800
Published: 2017
Journal Articles

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Clinical Trials & Observations Brief Report
Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe, Nicole Prutsch, Lukas Kazianka, Sinan Gültekin, Gregor Hoermann, Marius E. Mayerhoefer, Georg Hopfinger, Alexander Hauswirth, Michael Panny, Marie-Bernadette Aretin, Bernadette Hilgarth, Wolfgang R. Sperr, Peter Valent, Ingrid Simonitsch-Klupp, Richard Moriggl, Olaf Merkel, Lukas Kenner, Ulrich Jäger, Stefan Kubicek, Philipp B. Staber
Journal: Blood
Blood (2017) 130 (23): 2499–2503.
https://doi.org/10.1182/blood-2017-05-785683
Published: 2017
Includes: Supplemental data
Journal Articles

Palbociclib treatment of FLT3 -ITD + AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6

Iris Z. Uras, Gina J. Walter, Ruth Scheicher, Florian Bellutti, Michaela Prchal-Murphy, Anca S. Tigan, Peter Valent, Florian H. Heidel, Stefan Kubicek, Claudia Scholl, Stefan Fröhling, Veronika Sexl
Journal: Blood
Blood (2016) 127 (23): 2890–2902.
https://doi.org/10.1182/blood-2015-11-683581
Published: 2016
Includes: Supplemental data